Yi Lou

General Technology Group Pharmaceutical Holding Ltd. provides pharmaceutical and medical industry investment, asset management, and health consulting services. The company is based in Beijing, China and is ultimately controlled by the Government of China.

China General Technology Group Holding Co Ltd. engages in the operation as a state-owned investment holding company specializing in distribution of industrial equipment and medical devices. It focuses on the development of three core businesses: advanced manufacturing and technical service consulting, medicine and medical health, and trade and engineering contracting. It is divided into eight sub-fields, such as equipment manufacturing, new materials, inspection and certification, medicine, medical, health, engineering contracting, and trade. The company was founded on March 18, 1998 and is headquartered in Beijing, China.

Shanghai Biochip Co., Ltd. (dba ShanghaiBio Corp.) performs specialty R&D services for global pharma/biotech companies. Situated on its own 10-acre campus in the heart of Shanghai's Zhangjiang Hi-Tech Park, China's Bio/Pharma Valley, ShanghaiBio operates in seven buildings totaling 220,000 SQF that contain offices and laboratories. Its labs provide GLP/GMP-compliant services and continually undergo rigorous internal and external QA audits. The scientific staff is chiefly home-grown talent trained by professionals schooled in western ways. The company was founded in August 2001 and is headquartered in Shanghai, China.